Welcome to our dedicated page for Rcm Tech news (Ticker: RCMT), a resource for investors and traders seeking the latest updates and insights on Rcm Tech stock.
RCM Technologies, Inc. reports company updates as a Nasdaq-listed business and technology solutions provider serving health care, engineering, aerospace and defense, process and industrial, life sciences, and data and solutions markets. Its announcements center on the deployment of engineering, specialty health care, and information technology services for customers operating in infrastructure, modernization, and resource-related industries.
Recurring news includes quarterly and annual financial results, related conference call notices, segment commentary, GAAP and non-GAAP performance measures, and capital-market updates such as index membership. Company releases commonly discuss revenue, gross profit, net income, adjusted EBITDA, diluted earnings per share, and operating trends across its service categories.
RCM Technologies (Nasdaq: RCMT) reported strong quarterly and annual results for the periods ended January 3, 2026. Q4 revenue was $86.5M, up 12.4% year-over-period; Q4 GAAP net income was $6.1M, $0.80 diluted EPS. Q4 adjusted EBITDA was $9.3M, up 49.0%.
For the fifty-three weeks, revenue was $319.4M, up 14.7%; GAAP net income was $16.3M, $2.14 diluted EPS; adjusted EBITDA was $30.7M, up 18.9%. The company will not hold a conference call; see the Form 10-K for more detail.
RCM Technologies (Nasdaq: RCMT) reported results for the 13 and 39 weeks ended September 27, 2025. Q3 revenue was $70.3M (+16.4% vs. prior year) with gross profit $19.4M. GAAP net income for the quarter was $2.3M or $0.30 diluted EPS; adjusted EBITDA (non-GAAP) was $5.5M. For the 39-week period, revenue was $232.9M (+15.6% YoY), gross profit $63.7M, GAAP net income $10.2M (diluted EPS $1.34) and adjusted EBITDA $21.4M. Adjusted diluted EPS rose to $1.73 (+12.3% YoY). Management cited a record 2026 Engineering backlog as of end-October and scheduled a conference call for Nov 6, 2025 at 11:30 a.m. ET.
RCM Technologies (NasdaqGM: RCMT) will host a conference call on Thursday, November 6, 2025 at 11:30 a.m. ET to discuss financial results for the thirteen and thirty-nine weeks ended September 27, 2025.
Dial-in numbers: (888) 272-8703 (US) and (713) 936-6995 (international). The company is a business and technology solutions provider operating across Health Care, Engineering, Aerospace & Defense, Process & Industrial, Life Sciences and Data & Solutions.
Forward-looking statements in the release are subject to risks and uncertainties; investors are directed to the company’s SEC filings for risk factors and further details.
RCM Technologies (NASDAQ:RCMT) reported strong Q2 2025 financial results with notable growth across all segments. Revenue increased 13.0% to $78.2 million compared to Q2 2024. The company achieved GAAP net income of $3.8 million, or $0.50 per diluted share, and adjusted EBITDA of $8.1 million.
Key highlights include: gross profit growth of 11.4% to $22.3 million, adjusted net income per diluted share increase of 21.1% to $0.69, and strong performance across Specialty Health Care, Engineering, and Life Sciences segments. For the first half of 2025, revenue grew 15.3% to $162.6 million with net income of $8.0 million.
RCM Technologies (NASDAQ:RCMT) has scheduled a conference call for Thursday, August 7, 2025, at 11:30 a.m. Eastern time to discuss their financial results for the thirteen and twenty-six weeks ended June 28, 2025. Investors can join via phone using the dial-in numbers: (888) 272-8703 for domestic callers and (713) 936-6995 for international callers.
RCM Technologies is a business and technology solutions provider operating across multiple sectors including Health Care, Engineering, Aerospace & Defense, Process & Industrial, Life Sciences, and Data & Solutions. The company focuses on designing, building, and enabling industries of tomorrow through their specialized services.
RCM Technologies (NASDAQ:RCMT), a provider of engineering, healthcare, and technology solutions, has been added to the Russell 3000® and small-cap Russell 2000® Indexes as part of the 2025 Russell Indexes reconstitution, effective June 30, 2025.
The inclusion in these widely-used benchmark indexes is significant, as approximately $10.6 trillion in assets are benchmarked against Russell US Indexes as of June 2024. RCM Technologies operates in key market segments including Healthcare, Engineering, Aerospace & Defense, Process & Industrial, Life Sciences, and Data & Solutions.
Bradley Vizi, Executive Chairman of RCM Technologies, highlighted this as a significant milestone in the company's 50-year history, marking the beginning of a new phase as the company aims to increase its role in global infrastructure development.
RCM Technologies (RCMT) has scheduled a conference call for Thursday, May 8, 2025, at 10:30 a.m. Eastern time to discuss its financial results for the thirteen weeks ended March 29, 2025. Investors can join via phone using the dial-in numbers (888) 272-8703 for domestic callers and (713) 936-6995 for international callers.
RCM Technologies is a business and technology solutions provider operating across multiple key market segments including Health Care, Engineering, Aerospace & Defense, Process & Industrial, Life Sciences, and Data & Solutions. The company focuses on designing, building, and enabling industries of tomorrow.
RCM Technologies (RCMT) has reported its Q4 and fiscal year 2024 results, showing mixed performance. Q4 revenue increased 8.3% to $76.9 million compared to $71.0 million in Q4 2023, while gross profit remained flat at $21.6 million. However, Q4 GAAP net income decreased to $2.9 million ($0.37 per diluted share) from $5.3 million ($0.65 per diluted share) year-over-year.
For fiscal year 2024, revenue grew 5.8% to $278.4 million, with gross profit up 4.0% to $79.8 million. Annual GAAP net income declined to $13.3 million ($1.68 per diluted share) from $16.8 million ($1.96 per diluted share) in 2023. Adjusted EBITDA for 2024 slightly decreased to $25.9 million compared to $26.6 million in the previous year.
RCM Technologies (RCMT) has announced a conference call scheduled for Thursday, March 13, 2025 at 11:30 a.m. Eastern time to discuss financial results for the thirteen and fifty-two weeks ended December 28, 2024. Participants can join via phone using the following dial-in numbers: (888) 272-8703 for domestic callers and (713) 936-6995 for international callers.
RCM Technologies positions itself as a business and technology solutions provider operating in key market segments. The company specializes in:
- Health Care
- Engineering
- Aerospace & Defense
- Process & Industrial
- Life Sciences
- Data & Solutions